Tag: Aviptadil

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Aviptadil

NeuroRx, Relief, and Quantum Leap announce the inclusion of ZYESAMI™ (RLF-100™: aviptadil ...

Added to Collection on: 2021-01-11 06:00:00

Tags for this article:

Agencies of the United States government
SEC filings
Initial public offering
Prospectus
Forward-looking statement
Proxy statement
United States Securities Regulation
U.S. Securities and Exchange Commission
Stock market
Aviptadil
Food and Drug Administration
Articles
Jonathan C. Javitt
RELIEF THERAPEUTICS Holding AG
NASDAQ COMPOSITE INDEX
NeuroRx Inc.

Click the tags to see associated articles and topics

View Article Details
NeuroRx Announces ZYESAMI™ (aviptadil, RLF-100) Met the Primary Endpoint of Its Phase 2b/3 ...

Added to Collection on: 2021-03-29 05:03:45

Tags for this article:

Medical specialties
Medicine
Health
Intensive care medicine
Relief Therapeutics
Cycloserine/lurasidone
Aviptadil
Acute respiratory distress syndrome
COVID-19
Angiotensin-converting enzyme 2
Placebo
Mechanical ventilation
RELIEF THERAPEUTICS Holding AG
United States
NeuroRx Inc.

Click the tags to see associated articles and topics

View Article Details
NeuroRx Announces Zyesami™ (Aviptadil) Has Been Selected for Inclusion in NIH-Sponsored ...

Added to Collection on: 2021-04-06 04:52:30

Tags for this article:

U.S. Securities and Exchange Commission
73rd United States Congress
Agencies of the United States government
Financial markets
SEC filings
Shareholders
Corporate governance
Initial public offering
Prospectus
Securities Act
Proxy statement
Cycloserine/lurasidone
NeuroRx Inc.
Aviptadil

Click the tags to see associated articles and topics

View Article Details
(PRNewsfoto/NeuroRx)

Added to Collection on: 2021-04-06 04:52:30

Tags for this article:

Life Sciences
Health care
Health sciences
Antiviral drugs
Orphan drugs
COVID-19 drug development
Nucleotides
Remdesivir
Relief Therapeutics
Aviptadil
Gilead Sciences
National Institutes of Health
NeuroRx Inc.
RELIEF THERAPEUTICS Holding AG

Click the tags to see associated articles and topics

View Article Details
FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for ... - The Globe and Mail

Added to Collection on: 2024-02-16 17:03:18

Tags for this article:

COVID-19 drug development
Nitriles
Antiviral drugs
Remdesivir
Cycloserine/lurasidone
Emergency use authorization
Aviptadil
Food and Drug Administration
EUA
Relief Therapeutics
NRx Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo